{
    "2018-03-06": [
        [
            {
                "time": "2018-01-01",
                "original_text": "Novo Nordisk Has a Broad Portfolio for Type 2 Diabetes Care",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Broad Portfolio",
                        "Type 2 Diabetes"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Diabetes Care Segment Continues to Drive Growth for NVO in 2018",
                "features": {
                    "keywords": [
                        "Diabetes Care",
                        "Drive Growth",
                        "NVO",
                        "2018"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-01",
                "original_text": "Novo Nordisk Focuses on Raising the Bar in Research in 2018",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Raising the Bar",
                        "Research",
                        "2018"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}